trial · primary record
hydrocortisone acetate 50 mg
Hemorrhoidal Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 78 |
| Primary completion | 2027-01 |
| Primary endpoint | Efficacy of 50 mg and 75 mg hydrocortisone acetate suppositories compared to placebo, in the treatment of hemorrhoidal disease, using HDSIM patient reported outcome instrument |
| Registry ID | NCT07909291 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:43.517Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07909291
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.